Victory Capital Management
MGNX icon

Victory Capital Management’s MacroGenics MGNX Stock Holding History

Victory Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-33,750
Closed -$497K – 2514
2024
Q1 		$497K Buy
+33,750
New +$510K ﹤0.01% 1983
2023
Q2 		– Sell
-133,750
Closed -$959K – 2567
2023
Q1 		$959K Buy
+133,750
New +$806K ﹤0.01% 1712
2021
Q4 		– Sell
-1,965,101
Closed -$41.1M – 2822
2021
Q3 		$41.1M Buy
1,965,101
+315,629
+19% +$7.6M 0.04% 610
2021
Q2 		$44.3M Buy
1,649,472
+402,803
+32% +$11.8M 0.04% 604
2021
Q1 		$39.7M Buy
1,246,669
+1,179,339
+1,752% +$28.6M 0.04% 634
2020
Q4 		$1.54M Sell
67,330
-12,550
-16% -$289K ﹤0.01% 1602
2020
Q3 		$2.01M Sell
79,880
-2,900
-4% -$79.2K ﹤0.01% 1442
2020
Q2 		$2.31M Sell
82,780
-533,090
-87% -$9.26M ﹤0.01% 1387
2020
Q1 		$3.58M Buy
615,870
+292,212
+90% +$2.65M ﹤0.01% 1372
2019
Q4 		$3.52M Sell
323,658
-3,121
-1% -$30.9K ﹤0.01% 1317
2019
Q3 		$4.17M Buy
326,779
+220,179
+207% +$3.17M 0.01% 1220
2019
Q2 		$1.81M Buy
106,600
+3,670
+4% +$63K ﹤0.01% 1165
2019
Q1 		$1.85M Sell
102,930
-1,040
-1% -$18K ﹤0.01% 1102
2018
Q4 		$1.32M Sell
103,970
-1,800
-2% -$30.2K ﹤0.01% 1139
2018
Q3 		$2.27M Sell
105,770
-61,400
-37% -$1.31M ﹤0.01% 1079
2018
Q2 		$3.45M Sell
167,170
-9,430
-5% -$212K 0.01% 941
2018
Q1 		$4.44M Buy
+176,600
New +$4.29M 0.01% 843
2015
Q3 		– Sell
-588
Closed -$22K – 1676
2015
Q2 		$22K Buy
+588
New +$19.3K ﹤0.01% 1586

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management's MGNX Position: Q2 2024 in Review

Victory Capital Management sold out of MacroGenics (MGNX) in Q2 2024, closing a stake of 33,750 shares — an estimated $497K sold.

Victory Capital Management first reported a position in MGNX in Q2 2015 and held it in 18 quarters. The position peaked at $44.3M in Q2 2021. 146 funds tracked by Wall St. Rank hold MGNX as of Q2 2024.

  • Victory Capital Management reported no remaining MacroGenics position as of Q2 2024 after selling out during the quarter.
  • Victory Capital Management sold 33,750 MacroGenics shares in Q2 2024, an estimated $497K.
  • Victory Capital Management first reported a position in MacroGenics in Q2 2015 and held it in 18 quarters.
  • Victory Capital Management's MacroGenics position peaked at $44.3M in Q2 2021.
  • 146 funds tracked by Wall St. Rank held MacroGenics as of Q2 2024.

Based on Victory Capital Management's 13F filing for Q2 2024, filed 5 Aug 2024.